Fovea's Series B Round

Fovea raised a round of funding on December 12, 2007.

Fovea is a privately-held biopharmaceutical company specialized in the development and commercialization of drugs for the treatment of ocular diseases, with a special focus on retinal pathologies.…

Articles about Fovea's Series B Round: